Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Zavadil, Jiri ^a,b   Ye, Huihui ^a   Liu, Zhaojian ^c   Wu, Jingjing ^c   Lee, Peng ^a   Hernando, Eva ^a   Soteropoulos, Patricia ^d   Toruner, Gokce A ^e   Wei, Jian Jun ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; JANUS KINASE; LET 7S; MESSENGER RNA; MICRORNA; MICRORNA 15; MICRORNA 16; MICRORNA 200A; MICRORNA 200B; MICRORNA 21; MICRORNA 23B; MICRORNA 27A; MICRORNA 296; MICRORNA 30A; MITOGEN ACTIVATED PROTEIN KINASE; RNA; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; PROTEIN;

ADULT; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 3Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NUCLEAR REPROGRAMMING; PREDICTION; PROTEIN EXPRESSION; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; UTERUS MYOMA; GENETICS; GENOMICS; HOMEOSTASIS; LEIOMYOMA; METABOLISM; MIDDLE AGED; MYOMETRIUM; PATHOLOGY; TUMOR CELL LINE; TUMOR GENE; UTERUS CANCER;

ADULT; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOMICS; HOMEOSTASIS; HUMANS; LEIOMYOMA; MICRORNAS; MIDDLE AGED; MYOMETRIUM; PROTEINS; RNA, MESSENGER; UTERINE NEOPLASMS;

EID: 77957866076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012362     Document Type: Article

References (46)

1. Flake GP, Andersen J, Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111: 1037-1054.
2. Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, et al. (2005) Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20: 852-863.
3. Kim VN (2005) Small RNAs: classification, biogenesis, and function. Mol Cells 19: 1-15.
4. Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568.
5. Croce CM, Calin GA (2005) MiRNAs, cancer, and stem cell division. Cell 122: 6-7.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
7. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101: 11755-11760.
8. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
9. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101: 9740-9744.
10. Zhang B, Pan X, Cobb GP, Anderson TA (2006) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
11. Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, et al. (2007) Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril 89: 1771-1776.
12. Pan Q, Luo X, Chegini N (2007) Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med 12: 227-240.
13. Wang T, Zhang X, Obijuru L, Laser J, Aris V, et al. (2007) A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 46: 336-347.
14. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) MiRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
15. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
16. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
17. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, et al. (2007) Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 104: 11400-11405.
18. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
19. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
20. Carney SA, Tahara H, Swartz CD, Risinger JI, He H, et al. (2002) Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest 82: 719-728.
21. Hoffman PJ, Milliken DB, Gregg LC, Davis RR, Gregg JP (2004) Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 82: 639-649.
22. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, opensource system for microarray data management and analysis. Biotechniques 34: 374-378.
23. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
24. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S (1997) Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol (Berl) 94: 525-531.
25. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S (1996) Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 40: 941-944.
26. Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H, et al. (2006) Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod 21: 57-67.
27. Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H, et al. (2005) Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod 21: 57-67.
28. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
29. Wei JJ, Chiriboga L, Mittal K (2005) Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril 84: 474-484.
30. Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, et al. (2010) Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 5: e8697.
31. Cochrane DR, Howe EN, Spoelstra NS, Richer JK (2010) Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol 2010: 821717.
32. Aqeilan RI, Calin GA, Croce CM (2010) MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17: 215-220.
33. Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, et al. (2010) Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol 116: 117-125.
34. Wei J, Chiriboga L, Mizuguchi M, Yee H, Mittal K (2005) Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol 18: 179-188.
35. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
36. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
37. Liu T, Papagiannakopoulos T, Puskar K, Qi S, Santiago F, et al. (2007) Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS ONE 2: e804.
38. Yu Z, Jian Z, Shen SH, Purisima E, Wang E (2007) Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res 35: 152-164.
39. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A 103: 2746-2751.
40. Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ (2007) Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185: 157-161.
41. Peng Y, Laser J, Ye G, Mittal K, Lee P, et al. (2007) Antiproliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res 6: 663.
42. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, et al. (2003) Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9: 541-549.
43. Catherino WH, Leppert PC, Stenmark MH, Payson M, Potlog-Nahari C, et al. (2004) Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 40: 204-217.
44. Chegini N, Verala J, Luo X, Xu J, Williams RS (2003) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 10: 161-171.
45. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
46. Luo X, Ding L, Xu J, Chegini N (2004) Gene Expression Profiling of Leiomyoma and Myometrial Smooth Muscle Cells In Response to TGF-{beta}. Endocrinology 146: 1097-1118.